Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Insomnia Pharmacological Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Insomnia Pharmacological Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Prescription Sleep Aids
      • 1.3.3 Over-the-Counter Sleep Aids
    • 1.4 Market Segment by Application
      • 1.4.1 Global Insomnia Pharmacological Treatment Market Share by Application (2019-2025)
      • 1.4.2 Homecare
      • 1.4.3 Clinic
      • 1.4.4 Hospital
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Insomnia Pharmacological Treatment Market Size
      • 2.1.1 Global Insomnia Pharmacological Treatment Revenue 2014-2025
      • 2.1.2 Global Insomnia Pharmacological Treatment Sales 2014-2025
    • 2.2 Insomnia Pharmacological Treatment Growth Rate by Regions
      • 2.2.1 Global Insomnia Pharmacological Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Insomnia Pharmacological Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Insomnia Pharmacological Treatment Sales by Manufacturers
      • 3.1.1 Insomnia Pharmacological Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Insomnia Pharmacological Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Insomnia Pharmacological Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Insomnia Pharmacological Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Insomnia Pharmacological Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Insomnia Pharmacological Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Insomnia Pharmacological Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Insomnia Pharmacological Treatment Market
    • 3.6 Key Manufacturers Insomnia Pharmacological Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Prescription Sleep Aids Sales and Revenue (2014-2019)
      • 4.1.2 Over-the-Counter Sleep Aids Sales and Revenue (2014-2019)
    • 4.2 Global Insomnia Pharmacological Treatment Sales Market Share by Type
    • 4.3 Global Insomnia Pharmacological Treatment Revenue Market Share by Type
    • 4.4 Insomnia Pharmacological Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Insomnia Pharmacological Treatment Sales by Application

    6 United States

    • 6.1 United States Insomnia Pharmacological Treatment Breakdown Data by Company
    • 6.2 United States Insomnia Pharmacological Treatment Breakdown Data by Type
    • 6.3 United States Insomnia Pharmacological Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Insomnia Pharmacological Treatment Breakdown Data by Company
    • 7.2 European Union Insomnia Pharmacological Treatment Breakdown Data by Type
    • 7.3 European Union Insomnia Pharmacological Treatment Breakdown Data by Application

    8 China

    • 8.1 China Insomnia Pharmacological Treatment Breakdown Data by Company
    • 8.2 China Insomnia Pharmacological Treatment Breakdown Data by Type
    • 8.3 China Insomnia Pharmacological Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Insomnia Pharmacological Treatment Breakdown Data by Company
    • 9.2 Rest of World Insomnia Pharmacological Treatment Breakdown Data by Type
    • 9.3 Rest of World Insomnia Pharmacological Treatment Breakdown Data by Application
    • 9.4 Rest of World Insomnia Pharmacological Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Insomnia Pharmacological Treatment Sales by Countries
      • 9.4.2 Rest of World Insomnia Pharmacological Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Eisai, Co. Ltd. (Japan)
      • 10.1.1 Eisai, Co. Ltd. (Japan) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.1.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.1.5 Eisai, Co. Ltd. (Japan) Recent Development
    • 10.2 Merck & Co., Inc. (U.S.)
      • 10.2.1 Merck & Co., Inc. (U.S.) Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.2.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.2.5 Merck & Co., Inc. (U.S.) Recent Development
    • 10.3 Meda Consumer Healthcare Inc. (U.S.)
      • 10.3.1 Meda Consumer Healthcare Inc. (U.S.) Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.3.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.3.5 Meda Consumer Healthcare Inc. (U.S.) Recent Development
    • 10.4 Pfizer, Inc. (U.S.)
      • 10.4.1 Pfizer, Inc. (U.S.) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.4.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.4.5 Pfizer, Inc. (U.S.) Recent Development
    • 10.5 Sanofi (France)
      • 10.5.1 Sanofi (France) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.5.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.5.5 Sanofi (France) Recent Development
    • 10.6 Takeda Pharmaceutical Company Ltd. (Japan)
      • 10.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.6.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Recent Development
    • 10.7 Pernix Therapeutics (U.S.)
      • 10.7.1 Pernix Therapeutics (U.S.) Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.7.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.7.5 Pernix Therapeutics (U.S.) Recent Development
    • 10.8 Purdue Pharma L.P. (U.S.)
      • 10.8.1 Purdue Pharma L.P. (U.S.) Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Insomnia Pharmacological Treatment
      • 10.8.4 Insomnia Pharmacological Treatment Product Introduction
      • 10.8.5 Purdue Pharma L.P. (U.S.) Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Insomnia Pharmacological Treatment Sales Channels
      • 11.2.2 Insomnia Pharmacological Treatment Distributors
    • 11.3 Insomnia Pharmacological Treatment Customers

    12 Market Forecast

    • 12.1 Global Insomnia Pharmacological Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Insomnia Pharmacological Treatment Sales Forecast by Type
    • 12.3 Global Insomnia Pharmacological Treatment Sales Forecast by Application
    • 12.4 Insomnia Pharmacological Treatment Forecast by Regions
      • 12.4.1 Global Insomnia Pharmacological Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Insomnia Pharmacological Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Insomnia Pharmacological Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Insomnia Pharmacological Treatment.

      This report studies the global market size of Insomnia Pharmacological Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Insomnia Pharmacological Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Eisai, Co. Ltd. (Japan)
      Merck & Co., Inc. (U.S.)
      Meda Consumer Healthcare Inc. (U.S.)
      Pfizer, Inc. (U.S.)
      Sanofi (France)
      Takeda Pharmaceutical Company Ltd. (Japan)
      Pernix Therapeutics (U.S.)
      Purdue Pharma L.P. (U.S.)

      Market Segment by Product Type
      Prescription Sleep Aids
      Over-the-Counter Sleep Aids

      Market Segment by Application
      Homecare
      Clinic
      Hospital

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Insomnia Pharmacological Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Insomnia Pharmacological Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Insomnia Pharmacological Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now